Ray Past Earnings Performance

Past criteria checks 0/6

Ray's earnings have been declining at an average annual rate of -33.5%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 31.2% per year.

Key information

-33.5%

Earnings growth rate

-38.6%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate31.2%
Return on equity-2.3%
Net Margin-1.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence

Mar 14
The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence

Is Ray (KOSDAQ:228670) Using Too Much Debt?

Mar 16
Is Ray (KOSDAQ:228670) Using Too Much Debt?

What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?

Feb 21
What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?

With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?

Feb 02
With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?

We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide

Jan 14
We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide

If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns

Dec 27
If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns

Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Dec 08
Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?

Nov 19
Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?

Revenue & Expenses Breakdown
Beta

How Ray makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A228670 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23145,882-2,14650,1426,986
30 Sep 23145,1437,51845,8467,054
30 Jun 23139,5916,46244,6616,863
31 Mar 23131,3965,34639,5366,336
31 Dec 22128,9987,95734,6536,163
30 Sep 22108,356-5,62830,8965,979
30 Jun 22100,533-2,98426,1025,829
31 Mar 2293,0261,24122,2775,481
31 Dec 2190,336-1320,6415,063
30 Sep 2184,68112,72717,4104,667
30 Jun 2173,6769,98816,8474,315
31 Mar 2157,8034,64516,4574,411
31 Dec 2055,2057,90415,4094,180
30 Sep 2057,2607,97916,2563,858
30 Jun 2061,7818,89116,8313,484
31 Mar 2071,98612,34016,7423,178
31 Dec 1973,10911,55516,7853,220
30 Sep 1969,51210,84316,1183,207

Quality Earnings: A228670 is currently unprofitable.

Growing Profit Margin: A228670 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A228670 is unprofitable, and losses have increased over the past 5 years at a rate of 33.5% per year.

Accelerating Growth: Unable to compare A228670's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A228670 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.8%).


Return on Equity

High ROE: A228670 has a negative Return on Equity (-2.32%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.